Congress Asset Management’s LeMaitre Vascular LMAT Stock Holding History

Congress Asset Management’s Portfolio LMAT Stock Details LMAT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$92.5M	Buy	963,706 +129,177	+15%	+$13.2M	0.57%	68
2026 Q1	$91.1M	Buy	834,529 +102,198	+14%	+$9.74M	0.65%	53
2025 Q4	$59.4M	Buy	732,331 +40,065	+6%	+$3.45M	0.42%	89
2025 Q3	$60.6M	Buy	692,266 +18,298	+3%	+$1.63M	0.4%	96
2025 Q2	$56M	Buy	673,968 +29,553	+5%	+$2.47M	0.38%	106
2025 Q1	$54.1M	Sell	644,415 -77,910	-11%	-$7.25M	0.4%	99
2024 Q4	$66.6M	Buy	722,325 +13,009	+2%	+$1.25M	0.45%	88
2024 Q3	$65.9M	Buy	709,316 +18,295	+3%	+$1.59M	0.45%	86
2024 Q2	$56.9M	Buy	691,021 +24,938	+4%	+$1.83M	0.41%	87
2024 Q1	$44.2M	Buy	666,083 +71,411	+12%	+$4.41M	0.32%	99
2023 Q4	$33.8M	Buy	594,672 +86,293	+17%	+$4.52M	0.27%	106
2023 Q3	$27.7M	Buy	508,379 +135,266	+36%	+$8.02M	0.24%	107
2023 Q2	$25.1M	Buy	373,113 +361,296	+3,057%	+$22M	0.22%	107
2023 Q1	$608K	Buy	11,817 +11	+0.1%	+$534	0.01%	321
2022 Q4	$543K	Sell	11,806 -2,836	-19%	-$133K	0.01%	332
2022 Q3	$742K	Buy	14,642 +108	+0.7%	+$5.4K	0.01%	312
2022 Q2	$662K	Buy	14,534 +1,641	+13%	+$73.4K	0.01%	323
2022 Q1	$599K	Buy	12,893 +2,319	+22%	+$104K	0.01%	324
2021 Q4	$531K	Hold	10,574	–	–	﹤0.01%	336
2021 Q3	$561K	Hold	10,574	–	–	﹤0.01%	320
2021 Q2	$645K	Sell	10,574 -113	-1%	-$6K	0.01%	316
2021 Q1	$521K	Buy	10,687 +65	+0.6%	+$3.05K	﹤0.01%	322
2020 Q4	$430K	Buy	10,622 +135	+1%	+$4.83K	﹤0.01%	321
2020 Q3	$341K	Buy	10,487 +82	+0.8%	+$2.46K	﹤0.01%	308
2020 Q2	$275K	Buy	+10,405	New	+$272K	﹤0.01%	310
2020 Q1	–	Sell	-7,760	Closed	-$279K	–	343
2019 Q4	$279K	Buy	+7,760	New	+$268K	﹤0.01%	333
2018 Q2	–	Sell	-52,955	Closed	-$1.92M	–	376
2018 Q1	$1.92M	Buy	52,955 +10,057	+23%	+$348K	0.03%	270
2017 Q4	$1.37M	Buy	42,898 +2,611	+6%	+$89.4K	0.02%	289
2017 Q3	$1.51M	Buy	40,287 +5,694	+16%	+$194K	0.02%	287
2017 Q2	$1.08M	Buy	34,593 +4,110	+13%	+$119K	0.02%	196
2017 Q1	$751K	Buy	+30,483	New	+$716K	0.01%	204

Other funds holding LMAT

AAS

Annex Advisory Services Brookfield, Wisconsin $5.86B AUM 21.83% 1-Year Est. Return

Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return

LTAS

Linden Thomas Advisory Services Charlotte, North Carolina $1.24B AUM 47.37% 1-Year Est. Return

CCG

Chatham Capital Group Savannah, Georgia $783M AUM 31.99% 1-Year Est. Return

YIH

Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return

HWAM

Hennion & Walsh Asset Management Parsippany, New Jersey $3.5B AUM 41.95% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

PWG

Portside Wealth Group Provo, Utah $858M AUM 26.82% 1-Year Est. Return

YCM

Yousif Capital Management Bloomfield Hills, Michigan $8.94B AUM 42.6% 1-Year Est. Return

CFMC

Curbstone Financial Management Corp Manchester, New Hampshire $587M AUM 24.61% 1-Year Est. Return

Congress Asset Management's LMAT Position: Q2 2026 in Review

Congress Asset Management increased its LeMaitre Vascular (LMAT) stake by 15% in Q2 2026, buying an estimated $13.2M and bringing the position to 963,706 shares worth $92.5M. The position accounts for 0.57% of the portfolio, ranked #68.

Congress Asset Management first reported a position in LMAT in Q1 2017 and has held it in 31 quarters since. 32 funds tracked by Wall St. Rank hold LMAT as of Q2 2026.

Congress Asset Management held 963,706 shares of LeMaitre Vascular worth $92.5M as of Q2 2026.
Congress Asset Management bought 129,177 LeMaitre Vascular shares in Q2 2026, an estimated $13.2M.
LeMaitre Vascular made up 0.57% of Congress Asset Management's portfolio in Q2 2026, its #68 holding.
Congress Asset Management first reported a position in LeMaitre Vascular in Q1 2017 and has held it in 31 quarters since.
32 funds tracked by Wall St. Rank held LeMaitre Vascular as of Q2 2026.

Based on Congress Asset Management's 13F filing for Q2 2026, filed 7 Jul 2026.